The advisory comes amid rising global concern about the new omicron COVID-19 variant, which prompted the U.S. to restrict travel from South Africa and seven other countries. The restrictions do not apply to U.S. citizens. Early evidence suggests omicron may increase the risk of reinfection, while additional studies are underway to determine how the variant may affect illness severity and the effectiveness of existing treatments or vaccines.
While cases of omicron have not yet been confirmed in the U.S., “inevitably it will be here,” Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, told ABC News Nov. 28.
Health officials in New York City issued the indoor mask advisory as they expect to detect cases of the new strain within a few days.
“We do anticipate detecting omicron in New York City in the coming days based on what we know about its global spread,” Dave Chokshi, MD, the city’s health commissioner, said Nov. 29, according to ABC7 New York.
Statewide, the daily average of new COVID-19 cases on Nov. 28 was 5,809, up 9 percent over the last 14 days. Meanwhile, the daily average of COVID-19 hospitalizations in New York was 2,794 on Nov. 28, marking a 23 percent rise over the last two weeks, according to data from The New York Times.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
